Macrolide Resistance in Mycoplasma pneumoniae , Israel, 2010 (original) (raw)

Macrolide Resistance inMycoplasma pneumoniae, Israel, 2010

Carlos Hidalgo-Grass

Emerging Infectious Diseases, 2011

View PDFchevron_right

Macrolide resistance in Belgian Streptococcus pneumoniae

Jan Verhaegen

Journal of Antimicrobial Chemotherapy, 2000

View PDFchevron_right

First Report of Macrolide Resistance in a Mycoplasma pneumoniae Isolate Causing Community-Acquired Pneumonia in Spain

Juan Caballero

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Meta-analysis of Macrolide Resistance Pattern of Mycoplasma pneumoniae in the World

neda kazeminia

View PDFchevron_right

Macrolide Resistance ofMycoplasma pneumoniae,South Korea, 2000–2011

Ki Hong

Emerging Infectious Diseases, 2013

View PDFchevron_right

Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia

Ki Hong

BMC infectious diseases, 2017

View PDFchevron_right

Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection

Nicola Principi

The Journal of antimicrobial chemotherapy, 2013

View PDFchevron_right

Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease

Rebecca Wilson

American Journal of Respiratory and Critical Care Medicine, 2006

View PDFchevron_right

The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae

Josef Yayan

Drug Design, Development and Therapy, 2014

View PDFchevron_right

No detection of macrolide-resistant Mycoplasma pneumoniae from Swedish patients, 1996–2013

Kåre Bondeson

Infection Ecology & Epidemiology

View PDFchevron_right

Genetic Determinants of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium and Their Prevalence in Moscow, Russia

Roman Kozlov

Pathogens, 2023

View PDFchevron_right

Cluster of Macrolide-Resistant Mycoplasma pneumoniae Infections in Illinois in 2012

Kenneth Soyemi

Journal of Clinical Microbiology, 2013

View PDFchevron_right

Macrolide-Resistant Mycoplasma pneumoniae in Humans, Ontario, Canada, 2010–2011

Jonathan Gubbay

Emerging Infectious Diseases, 2013

View PDFchevron_right

Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis

Armelle Menard

Journal of Antimicrobial Chemotherapy, 2009

View PDFchevron_right

A study on molecular characterization of macrolide resistance mechanism among isolates of Streptococcus pneumoniae from the southern Marmara region of …

Cuneyt Ozakin

journals.tubitak.gov.tr

View PDFchevron_right

Macrolide resistance in Mycoplasma genitalium in Catalonia, Spain: a 1 year prospective study

Nuria Prim

Journal of Antimicrobial Chemotherapy, 2021

View PDFchevron_right

Detection of Macrolide Resistance in Mycoplasma pneumoniae by Real-Time PCR and High-Resolution Melt Analysis

Jonas Winchell

Antimicrobial Agents and Chemotherapy, 2008

View PDFchevron_right

High Prevalence of Macrolide Resistance inMycoplasma pneumoniaeIsolates from Adult and Adolescent Patients with Respiratory Tract Infection in China

Jian-zhong Zhang

Clinical Infectious Diseases, 2010

View PDFchevron_right

Studies on an epidemic of respiratory disease caused by Mycoplasma pneumoniae

T. Feizi

BMJ, 1967

View PDFchevron_right

Clinical characteristics of macrolide-resistant Mycoplasma pneumoniae infections among hospitalised children in Singapore

Chia Chong

Annals Academy of Medicine Singapore, 2022

View PDFchevron_right

Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure

Kai N. Cheong

Journal of Microbiology, Immunology and Infection, 2016

View PDFchevron_right

Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt Analysis

Catriona Bradshaw

PloS one, 2012

View PDFchevron_right

First Description of Macrolide-Resistant Mycoplasma pneumoniae in Adults with Community-Acquired Pneumonia in Italy

rosanna mallamaci

BioMed Research International, 2019

View PDFchevron_right

P1 gene of Mycoplasma pneumoniae isolated from 2016 to 2019 and relationship between genotyping and macrolide resistance in Hokkaido, Japan

Hideaki Kikuta

Journal of Medical Microbiology, 2021

View PDFchevron_right

Course of Lower Respiratory Tract Infection in Young People Treated at the Military Hospital of Smolensk Garrison with Detected Mycoplasma pneumoniae Carrying a Macrolide-Resistant Mutation in 23S rRNA Gene

Roman Kozlov

Pathogens, 2023

View PDFchevron_right

Resistance Mechanism Against Fluoroquinolones inMycoplasma hyopneumoniaeField Isolates

Johan Peeters

Microbial Drug Resistance, 2007

View PDFchevron_right

Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013

Jonas Winchell

Journal of clinical microbiology, 2015

View PDFchevron_right

Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland

Christoph Berger

Swiss Medical Weekly, 2014

View PDFchevron_right

Antimicrobial Susceptibility of Mycoplasma pneumoniae Isolates and Molecular Analysis of Macrolide-Resistant Strains from Shanghai, China

Yang Liu

Antimicrobial Agents and Chemotherapy, 2009

View PDFchevron_right

Characterization of In Vivo Acquired Resistance of Mycoplasma hyopneumoniae to Macrolides and Lincosamides

Dominiek Maes

Microbial Drug Resistance, 2005

View PDFchevron_right

Characterization of In Vivo Acquired Resistance of Mycoplasma hyopneumoniae to Macrolides and Lincosamides

Jo Vicca

Microbial Drug Resistance, 2005

View PDFchevron_right